GIMAP8 Activators
GIMAP8 Activators are a collection of chemical entities that indirectly bolster the functional activity of GIMAP8 through diverse signaling pathways within immune cells. Compounds such as Forskolin and Ionomycin operate by elevating intracellular cAMP and calcium levels respectively, which in turn activate protein kinases like PKA and calcium-dependent pathways that may phosphorylate proteins and transcription factors to enhance GIMAP8 activity. This is particularly important in modulating T lymphocyte survival and function, a key aspect of GIMAP8's role. Similarly, PMA activates PKC, potentially affecting cellular processes that upregulate GIMAP8 activity, while BIM-1's selective inhibition of PKC isoforms might shift signaling to support GIMAP8's involvement in T cell survival. Anisomycin and Roscovitine, by activating stress-activated protein kinases and influencing the cell cycle, respectively, might alter immune cell function where GIMAP8 is critical. LY294002 and Rapamycin, through their actions on the PI3K/Akt and mTOR pathways, could indirectly lead to the enhancement of GIMAP8 function, as these pathways are integral to T cell homeostasis and differentiation.
Moreover, compounds like SB203580, Thapsigargin, and U0126 indirectly contribute to the activation of GIMAP8 by influencing cytokine signaling and T cell receptor pathways through the modulation of MAPK signaling and calcium homeostasis. SB203580's inhibition of p38 MAPK, Thapsigargin's increase in cytosolic calcium, and U0126's impact on the ERK pathway all play a role in the cellular signaling environment that can enhance GIMAP8's activity. Okadaic Acid, by inhibiting protein phosphatases, leads to an increase in protein phosphorylation, thereby modulating signaling pathways that could potentiate GIMAP8's role in T cell signaling. Collectively, these GIMAP8 Activators, through targeted effects on signaling molecules and pathways, facilitate the enhancement of GIMAP8's function in immune regulation without direct activation or upregulation of expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate proteins and transcription factors that enhance the functional activity of GIMAP8 by promoting survival pathways in immune cells. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). Activated PKC can then phosphorylate substrates that may upregulate GIMAP8 activity, potentially by modulating the cellular environment in T lymphocytes where GIMAP8 is typically expressed. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, thereby activating calcium-dependent signaling pathways. These pathways can lead to the activation of NFAT and other transcription factors that enhance GIMAP8 activity, supporting its role in immune cell regulation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases such as JNK. The activation of these pathways can lead to the enhancement of immune cell function where GIMAP8 is implicated in survival and cell death decisions. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase inhibitor that can lead to cell cycle arrest. By altering the cell cycle, it can shift the balance of cellular signaling to favor pathways where GIMAP8 is active, particularly in lymphocyte development and function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
BIM-1 is a specific inhibitor of PKC. By selectively inhibiting certain PKC isoforms, it could shift signaling to favor pathways that indirectly enhance GIMAP8's role in T cell survival and apoptosis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can modulate the PI3K/Akt pathway, which is involved in cell survival. Inhibition of this pathway can indirectly lead to the enhancement of GIMAP8 activity by affecting T cell homeostasis where GIMAP8 is relevant. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. By inhibiting p38 MAPK, it can affect the balance of signaling pathways and indirectly enhance the activity of GIMAP8 in immune cells, possibly by altering cytokine signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the pathway that regulates cell growth and survival. This inhibition can lead to an enhanced GIMAP8 activity by indirectly affecting T cell differentiation and function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which could activate calcium-dependent signaling pathways that enhance GIMAP8 function in immune cell signaling. | ||||||